Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment of very preterm infants at
high-risk for lung and brain injury with low dose hydrocortisone results in improved
pulmonary and neurologic outcomes.
Phase:
Phase 2
Details
Lead Sponsor:
Nationwide Children's Hospital
Collaborators:
National Institute of Neurological Disorders and Stroke (NINDS) National Institutes of Health (NIH)